Status:

TERMINATED

Liking Adaptation to Beverages of Varying Sweetness Levels After Prolonged Exposure

Lead Sponsor:

PepsiCo Global R&D

Conditions:

Sweetness Liking Adaptation

Eligibility:

All Genders

25-55 years

Phase:

NA

Brief Summary

This is a double-blind, controlled, parallel, randomized sensory study. The study will consist of two cohorts; habitual regular full-calorie Carbonated Soft Drink (CSD) consumers and habitual low-calo...

Eligibility Criteria

Inclusion

  • Healthy adults 25-55 years of age
  • Habitually consume regular or diet carbonated soft drinks (CSD)
  • Willing and able to consume at least one CSD beverage daily for a total of 6 months and abstain from other sweetened beverages
  • Willing and able to complete questionnaires regarding dietary intake and sensory perception
  • Has internet access via computer, phone or other device and is able to maintain internet access throughout the trial in order to complete daily online questionnaires.
  • Participant is judged to be in good health on the basis of medical history and the general health and lifestyle questionnaire.
  • Participant is willing to maintain his or her habitual diet, smoking habits and physical activity patterns, including habitual use of study approved medications and/or dietary supplements throughout the study period.
  • Participant understands the study procedures and signs forms providing informed consent to participate in the study and authorization for release of relevant protected health information to the study Investigators.

Exclusion

  • Regular smoker (more than 1 cigarette per week)
  • History or presence of clinically important endocrine (including type 1 or 2 diabetes mellitus), cardiovascular, pulmonary, biliary, renal, hepatic, pancreatic, or neurologic disorders that, in the opinion of the Clinical Investigator, could interfere with the interpretation of the study results.
  • Extreme dietary habits, including but not limited to vegetarian diets and intentional consumption of a high fiber diet, gluten-free, low-carb, vegan, ketogenic.
  • Extreme changes to physical activity
  • Females who are pregnant, planning to be pregnant during the study period, lactating, or of childbearing potential and unwilling to commit to the use of a medically approved form of contraception throughout the study period.
  • Recent history (within 12 months of screening; Visit 1) of alcohol or substance abuse. Alcohol abuse is defined as \>14 drinks per week (1 drink = 12 oz beer, 5 oz wine, or 1½ oz distilled spirits).
  • Individual has a condition the Clinical Investigator believes would interfere with his or her ability to provide informed consent, comply with the study protocol, or which might confound the interpretation of the study results or put the participant at undue risk.
  • Dislike of study product taste
  • Participation in another clinical trial within past 30 days and participation in a PepsiCo clinical trial in the past 6 months.
  • People who have phenylketonuria (low calorie sweetened beverages contain aspartame)

Key Trial Info

Start Date :

January 14 2020

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

March 11 2020

Estimated Enrollment :

170 Patients enrolled

Trial Details

Trial ID

NCT04284462

Start Date

January 14 2020

End Date

March 11 2020

Last Update

June 16 2020

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

BioFortis Innovation Services

Addison, Illinois, United States, 60101